Journal
JOURNAL OF CLINICAL MEDICINE
Volume 12, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/jcm12093107
Keywords
hemodialysis; immune response; inflammation; lymphocytes; Th1; Th2; IFN-gamma; Th17; B cells; natural killer cells; Annexin V; proliferation
Categories
Ask authors/readers for more resources
Hemodialysis treatment has a significant impact on the patient's immune system, reshaping acquired immune components and causing an imbalance of T cell counterparts. CD3 cells are impaired while CD4 and CD8 cells increase and produce pro-inflammatory factors. B cells, monocytes, and NK cells are not affected by the dialysis procedure.
Hemodialysis (HD) is known to trigger a chronic inflammatory status, affecting the innate and acquired immune response. This study was aimed at a comparative analysis of immune cell subsets, proliferation, and apoptosis in subjects receiving chronic HD treatment with respect to a healthy control. Regardless of the dialysis filter used, we observed a reshaping of the acquired immune component both with respect to healthy patients and between the various sessions of dialysis treatment, with an impairment of CD3 cells, along with an increase in CD4 and CD8 cell populations producing pro-inflammatory factors such as IL-17 and IFN-gamma. The population of B cells, monocytes and NK cells were not impaired by the dialysis procedure. These results confirmed the high impact of the HD treatment on the patient's immune system, underlying the imbalance of T cell counterparts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available